Chemotherapy-Induced Hair Loss
Prevalence: Affects 65-85% of chemotherapy patients depending on regimen
About
Rapid, diffuse hair loss (anagen effluvium) caused by cytotoxic chemotherapy agents that target rapidly dividing cells, including hair matrix keratinocytes. Hair typically regrows after treatment completion, though texture and color may change.
Common Symptoms
Risk Factors
- Taxane chemotherapy
- Anthracycline chemotherapy
- Combination regimens
- Higher doses
Frequently Asked Questions
How is the evidence for Chemotherapy-Induced Hair Loss supplements graded?
What are common symptoms of Chemotherapy-Induced Hair Loss?
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.